ClinicalTrials.govpublic full text
Urokinase Plasminogen Activator Receptor in Abiraterone Treated Patients With Castration Resistant Prostate Cancer
prostatic neoplasms, castration-resistant prostate cancer, abiraterone, biomarker, urokinase plasminogen activator receptor, plasma, predictive markers, observational
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 838246
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.